Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00594620 · ClinicalTrials.gov registry record · Phase 2
Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy
A Phase 2 study, sponsored by University of Kansas Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
NCT00594620 is a Phase 2 study that was terminated before completion, run by University of Kansas Medical Center. The registered enrollment target is 11 participants.
The verdict
NCT00594620, a Phase 2 study, was terminated before completion, sponsored by University of Kansas Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
Study Summary
To determine the efficacy of soy/isoflavone supplementation on hot flashes in men who are being treated with luteinizing hormone-releasing hormone (LHRH) agonist therapy for control of advanced prostate cancer
Interventions
- DRUG Placebo
- DIETARY_SUPPLEMENT Flav-ein capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2004-08 |
| Est. Completion | 2010-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00594620
The ClinicalTrials.gov registry entry for NCT00594620 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00594620 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00594620 about?
NCT00594620 is a clinical study titled "Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy". To determine the efficacy of soy/isoflavone supplementation on hot flashes in men who are being treated with luteinizing hormone-releasing hormone (LHRH) agonist therapy for control of advanced prostate cancer
What is the current status of trial NCT00594620?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2004-08. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00594620?
The interventions under investigation include: Placebo (DRUG), Flav-ein capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00594620?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.